. Strains Used in This study
Strain
Genotype Source W303
MATα ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 (Santos and Ballesta, 1994) 
W303'
MATa ade2 his3∆1 leu2∆0 trp1 ura3∆0 Goyenechea and Warren, unpublished W303-GP0
MATα ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 URA3::P GAL1 -RPP0 (Santos and Ballesta, 1994) BSY28
MATα can1∆::MFA1pr-HIS3 lyp1∆ his3∆1 leu2∆0 ura3∆0 met15∆0 sdo1ts
Goyenechea and Warren, unpublished BY4741
MATa his3∆1 leu2∆0 ura3∆0 met15∆0 Open Biosystems FWY111 MATa ade2 his3∆ leu2∆ trp1∆ ura3∆ afg2-18 (drg1ts) (Pertschy et al., 2007) 
Y5563
MATα can1∆::MFA1pr-HIS3 lyp1∆ his3∆1 leu2∆0 ura3∆0 met15∆0 (Menne et al., 2007) AJY1539 MATa his3∆1 leu2∆0 ura3∆0 met15∆0 CRM1(T539C-HA) (Hedges et al., 2005) 
Supplemental Experimental Procedures

Strains and Plasmids
AJY2474, AJY2467, AJY2956, and AJY2957 were obtained by transforming the indicated plasmids into the appropriate heterozygous diploid deletion strain (Research Genetics) followed by sporulation. The GAL1 promoter and 3xHA tag was amplified from pFA6A pGAL-3HA::KanMX (Longtine et al., 1998) and integrated into W303 to generate AJY2981. AJY3005 and AJY3006 were derived from crossing BSY28 and AJY1699 (tif6∆ pTIF6), and AJY3013 and AJY3014 were from crossing AJY2981 with AJY1700 (tif6∆ pTIF6).
To make pAJ1875 RLP24 was amplified with primers AJO585
(GGCGTCGACTACGTTGATTCAAATGGC) and AJO613
(GCGCGACGTCACATCTCTAACTCCTAAG). The fragment was digested with SmaI and SalI and ligated into the same sites of pRS413. To make pAJ1895, PCR was carried out with primers AJO582 (GCGACTCGAGTGATATCTATCGCTTTTCTAGGA) and AJO1005 (GAATTAATTAATTTAGCCAACTTTCTGGC). The fragment was digested with SalI and PacI and ligated into the same sites of pAJ1139. pAJ2064 (GAL:RLP24-HA) and pAJ2065 (GAL:rlp24∆C-HA) were made with the same primers but different templates. AJO1064 (GCGGAATTCATGAGAATTTATCAATGCCA) and AJO1037
(GCTACGGCTAGAGCTCTGGAGCTTTTGAATC) were used to amplify rlp24∆C from pAJ1139 or RLP24 from pAJ1895. The PCR products were digested with EcoRI and PacI and ligated into pAJ1810. pAJ2074 (NOG1-myc) was made by PCR amplification using AJO1097 (CGTGAGCTCCTCTGGCTGTCTTGCAGATT) and AJO1098 (ACGTTAATTAAACGGAAATCTGTCTTACCGAC), and ligating the SstI and PacI cut fragment into the same sites of pAJ1026. To make pAJ2075 (DRG1-myc), DRG1 was amplified with AJO1099 (CGTCGGCCGAGTGGGCCCGTGGTTTATCA) and AJO1100 (ACGTTAATTAACGAAGATGAACCGCTTCTTAG). The PCR fragment was digested with EagI and PacI and ligated into the same sites of pAJ1026. formaldehyde for 15 min and nuclei were stained with Hoechst 33342 (Invitrogen).
HeLa Cell Work
Immunofluorescence and Microscopy
HeLa cells were fixed with 4% formaldehyde in PBS for 15 min at room temperature followed by permeabilization with cold methanol for 10 min at -20ºC. Cells were blocked with blotting grade 1% BSA (Promega) for 1 hr at room temperature and then incubated with mouse anti-MRTO4 (Santa Cruz Biotechnology) and rabbit anti-eIF6 (Cell Signaling) antibodies in blocking buffer at 4ºC overnight. After washing three times with PBS, cells were incubated with goat anti-mouse IgG Texas Red conjugated (Santa Cruz Biotechnology) and goat anti-rabbit IgG Alexa Fluor 488 conjugated (Invitrogen) secondary antibodies for 1 hr at room temperature. Cell nuclei were stained with Hoechst 33342 (Invitrogen). Fluorescence was visualized on an inverted microscope (Nikon Eclipse TE2000-E) fitted with a Plan Apo 60x/0.95 objective and a digital camera (Cascade II 512; Photometrics) controlled with the NIS Elements software (AR 3.0).
Images were prepared using Photoshop.
